InvestorsHub Logo
Followers 83
Posts 36201
Boards Moderated 0
Alias Born 03/09/2010

Re: Jimmy Joe post# 178981

Thursday, 01/14/2016 12:17:17 PM

Thursday, January 14, 2016 12:17:17 PM

Post# of 403280

Elite will immediately submit a 505(b)(2) New Drug Application for its lead opioid abuse-deterrent candidate ELI-200, immediate-release Oxycodone Hydrochloride 5mg, 10mg, 15 mg, 20 mg and 30mg capsules with sequestered Naltrexone Hydrochloride, for the treatment of moderate to severe pain with the United States Food and Drug Administration. FDA notification regarding acceptance of the submission for review is expected to take 6 to 12 weeks.


notice the word WILL?? LOL LOL next

THEY HATE ME CAUSE THEY AINT ME

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News